Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on August 14, 2025
Citric Acid Global Market Report 2025| Business Growth, Development Factors, Current and Future Trends till 2029
The Business Research Company’s Citric Acid Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 14, 2025 /EINPresswire.com/ -- How Much Is The Citric Acid Market Worth? In the last few …
Carbonated Soft Drinks Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029
The Business Research Company’s Carbonated Soft Drinks Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 14, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market Reports …
Cold Plasma Market CAGR to be at 17.6% from 2025 to 2029 | $6.93 Billion Industry Revenue by 2029
The Business Research Company’s Cold Plasma Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 14, 2025 /EINPresswire.com/ -- What Is The Projected Market Size …
Pet Sitting Market Set to Witness Significant Growth by 2025-2032 | A Place for Rover, Inc., Pets at Home, Wag! Group Co
BURLINGAME, CA, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- The Pet Sitting Market is estimated to be valued at USD 2.71 Bn in 2025 and is expected to reach USD 6.10 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.3% from …
Bovine Gelatin Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
The Business Research Company’s Bovine Gelatin Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 14, 2025 /EINPresswire.com/ -- What Is The Forecast For The Bovine Gelatin Market From …
Caffeinated Roasted Coffee Market Size, Share & Trends Analysis Report By Product
The Business Research Company’s Caffeinated Roasted Coffee Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 14, 2025 /EINPresswire.com/ -- What Is The Caffeinated Roasted Coffee …
Montage Gold Reports Fatal Accident at Its Koné Project in Côte d’Ivoire
ABIDJAN, Côte d’Ivoire, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Montage Gold Corp. (“Montage” or the “Company”) (TSX: MAU, OTCQX: MAUTF) is saddened to report that a Montage colleague passed away yesterday as a result of injuries sustained in an incident that …
Anti-Aging Market to Hit USD 168.9 Bn by 2035, Fueled by Preventive Skincare Adoption and Technological Advancements
Anti-Aging Market to Reach USD 168.9 Billion by 2035, Expanding at 7.0% CAGR, Driven by Preventive Skincare Demand and Technological Innovations WILMINGTON, DE, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- The global anti-aging market is …
Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
INVO Fertility Announces Second Quarter 2025 Financial Results
SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update
COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company’s listing on the TSX TORONTO, ONTARIO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “ …
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2026
Submitted two additional U.S. government funding proposals during the quarter, bringing the total proposals to US$137 million Accepted as a new member of U.S. Medical CBRN Defense Consortium, strengthening government and biodefense partnerships HALIFAX, …
Regional Health Properties, Inc. and SunLink Health Systems, Inc. Complete Merger
Atlanta, GA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) today announced the completion of the merger of SunLink Health Systems, Inc. (“SunLink”) with and into Regional, with Regional …
Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health
MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of specialist and allied health care via …
Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025
AUSTIN, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis …
BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025
MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and six months ended June 30, 2025 on Thursday, August 21, 2025 after market …
Range Impact Reports 2Q 2025 Financial Results
Cleveland, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reports its results for …
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
BOSTON and ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, …
Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights
PEMGARDA® (pemivibart) net product revenue of $11.8 million reported for Q2 2025, representing 413% growth year-over-year Invivyd’s target of near-term profitability (1H 2025) was not met but remains possible with the upcoming respiratory virus season …
Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19
Alignment follows Type C meeting for VYD2311 as previously disclosed BLA pathway for VYD2311 to be supported by a single, Phase 2/3 randomized, double-blind, placebo-controlled trial with a primary endpoint of reduction in symptomatic COVID-19, resembling …